List of Alvesco drug patents

Alvesco is owned by Covis.

Alvesco contains Ciclesonide.

Alvesco has a total of 1 drug patent out of which 0 drug patents have expired.

Alvesco was authorised for market use on 10 January, 2008.

Alvesco is available in aerosol, metered;inhalation dosage forms.

Alvesco can be used as maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. patent claims method for treating a respiratory disease in a child.

The generics of Alvesco are possible to be released after 01 February, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8371292 COVIS Use of ciclesonide for the treatment of respiratory diseases
Feb, 2028

(5 years from now)

Drugs and Companies using CICLESONIDE ingredient

Market Authorisation Date: 10 January, 2008

Treatment: Maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. patent claims method for treating a respiratory disease in a child

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in